Autoimmune Glomerular Disease Services in the UK- A National (UKKW 2024) - Jun 8, 2024 - Abstract #243; 562; Location: CAFE; "In England, blueteq access was available for rituximab for 78% (n=47), avacopan 78% (n=47), belimumab 50% (n=30) and voclosporin 48% (n=29). Responses were received from 72 adult nephrologists and 10 paediatricians from 55 centres. Responses were received from the eight NHS England renal networks, Northern Ireland (NI), Scotland and Wales. 74% (n=53) of adult nephrologists were from tertiary centres."
Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics • Rare Diseases • Renal Disease • Vasculitis
|
|
Survey Lucy Francis1,2; Jonathan Barratt3; Rachel B Jones1,2
|